Columbus, Ohio (June 17, 2024) – Avation Medical, an innovative neuromodulation and digital health company on a mission to make non-invasive, physiologic, closed-loop neuromodulation accessible
Avation Medical adds Vice President of Product Marketing and Customer Care New VP will market the Vivally® System for 46 million
Summation Jill Schiaparelli, Co-Founder and CEO of Avation Medical, is on a mission. She wants to help millions of patients who suffer from overactive bladder
Entrepreneur Of THE Year celebrates ambitious entrepreneurs who are shaping the future Columbus, Ohio (May 2, 2024) – Ernst & Young LLP (EY
For more information, contact Beth LaBreche beth@labreche.com 612-578-2834 New VP will work to make the Vivally® System accessible to 46 million people in the US
Maker of the Vivally® System wearable neuromodulation system for bladder issues passes rigorous standards for safety and quality Columbus, OH March. 4, 2024 Avation Medical,
Vivally is the first FDA-cleared, noninvasive, closed-loop, wearable tibial neuromodulation system and digital companion app for urge urinary incontinence and urinary urgency caused by overactive bladder (OAB) syndrome
Vivally is the first FDA-cleared, noninvasive, closed-loop, wearable tibial neuromodulation system and digital companion app for urge urinary incontinence and urinary urgency caused by overactive bladder (OAB) syndrome
Vivally is the first FDA-cleared, noninvasive, closed-loop, wearable tibial neuromodulation system and digital companion app for urge urinary incontinence and urinary urgency caused by overactive bladder (OAB) syndrome
Vivally® System, wearable closed-loop neuromodulation system and mobile application for urge
incontinence and urinary urge, recognized by MedTech Breakthrough Awards program for 2023
Revolutionary smart, wearable bladder control therapy and mobile app provides a new option
for urge urinary incontinence and urinary urgency for patients with no surgery, implants, or drugs
Avation Medical is pioneering a wearable digital therapy that could soon change the way that chronic health conditions are monitored and treated.
